Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) EPS (Weighted Average and Diluted) (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.14 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 133.33% to $0.14 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.49, a 0.0% change, with the full-year FY2025 number at $0.5, up 4.17% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.14 in Q4 2025 for SBC Medical Group Holdings, up from $0.12 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.21 in Q1 2025 to a low of $0.02 in Q2 2023.
  • Median EPS (Weighted Average and Diluted) over the past 3 years was $0.1 (2023), compared with a mean of $0.11.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 900.0% in 2024 and later plummeted 90.0% in 2025.
  • SBC Medical Group Holdings' EPS (Weighted Average and Diluted) stood at $0.15 in 2023, then plummeted by 60.0% to $0.06 in 2024, then surged by 133.33% to $0.14 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.14 (Q4 2025), $0.12 (Q3 2025), and $0.02 (Q2 2025) per Business Quant data.